JNJ - Technical Rebound Aligning With Major Drug‑Pricing NewsJohnson & JohnsonNYSE:JNJfadlidaudBased on the recent pharma agreements reported by Reuters — where 16 global drugmakers committed to lower U.S. prices in exchange for tariff exemptions — overall sector sentiment appears stable. Technically, price is reacting well within the demand zone, retesting structure and holding above key moving averages. This improves the probability of upside continuation but does not eliminate risk, especially given that FactCheck.org notes the long‑term impact of these agreements is still uncertain.